Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
About Tandem Diabetes Care, Inc. SAN DIEGO--(BUSINESS WIRE)--Apr. 9, 2024-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2024 results after the financial markets close on Thursday, May 2, 2024. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2024 financial and operating results.
聖地亞哥--(美國商業資訊)--2024年4月9日--領先的胰島素輸送和糖尿病技術公司Tandem Diabetes Care, Inc.（納斯達克股票代碼：TNDM）計劃在2024年5月2日星期四金融市場收盤後發佈其2024年第一季度業績。公司將在美國東部時間當天下午 4:30（太平洋時間下午 1:30）舉行電話會議和同步網絡直播，討論其2024年第一季度的財務和經營業績。
A live webcast of the call will be available on Tandem Diabetes Care's Investor Center website located at http://investor.tandemdiabetes.com in the "Events & Presentations" section. To access the call by phone, please use this link (https://register.vevent.com/register/BI12c72cd6ea054b01881ba78dd494dcc0) and you will be provided with dial-in details, including a personal pin.
電話會議的網絡直播將在Tandem Diabetes Care的投資者中心網站上播出，該網站位於 http://investor.tandemdiabetes.com 在 “活動和演示” 部分。要通過電話接聽電話，請使用此鏈接 (https://register.vevent.com/register/BI12c72cd6ea054b01881ba78dd494dcc0），您將獲得撥入詳細信息，包括個人密碼。
An archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care's Investor Center website located at http://investor.tandemdiabetes.com in the "Events & Presentations" section.
網絡直播的檔案將在活動結束後的30天內在Tandem Diabetes Care的投資者中心網站上公佈，該網站位於 http://investor.tandemdiabetes.com 在 “活動和演示” 部分中。
About Tandem Diabetes Care, Inc.
關於 Tandem 糖尿病護理公司
Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company's pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in San Diego, California. For more information, visit tandemdiabetes.com.
Tandem Diabetes Care是一家全球胰島素輸送和糖尿病技術公司，生產和銷售先進的自動化胰島素輸送系統，可減輕糖尿病管理的負擔，同時爲患者、他們的親人和醫療保健提供者創造新的可能性。該公司的泵產品組合包括Tandem Mobi系統和t: slim X2胰島素泵，兩者均採用Control-iq先進的混合閉環技術。Tandem 糖尿病護理總部位於加利福尼亞州聖地亞哥。欲了解更多信息，請訪問 tandemdiabetes.com。
Tandem Diabetes Care, the Tandem logo, Control-IQ, Tandem Mobi and t:slim X2 are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries.
Tandem Diabetes Care、Tandem 徽標、Control-IQ、Tandem Mobi 和 t: slim X2 是 Tandem Diabetes Care, Inc. 在美國和/或其他國家的註冊商標或商標。
View source version on businesswire.com: https://www.businesswire.com/news/home/20240409009517/en/
Media Contact:
858-366-6900
media@tandemdiabetes.com
媒體聯繫人：
858-366-6900
media@tandemdiabetes.com
Investor Contact:
858-366-6900
IR@tandemdiabetes.com
投資者聯繫人：
858-366-6900
IR@tandemdiabetes.com
Source: Tandem Diabetes Care, Inc.
來源：Tandem Diabetes Care, Inc.
